DALLAS, Texas, Sept.
10, 2019 /PRNewswire/ -- Puration,
Inc. (USOTC: PURA) ("PURA") today confirmed a coming
CBD infused beverage market survey coming from Goldman
Small Cap Research. The survey is part of a
recently announced pre-marketing campaign of PURA's
new CBD Infused beer, coffee and tea beverages. The
data collected will be used to target PURA's
marketing direction for CBD infused beer, coffee and
tea.
PURA recently implemented program to introduce CBD
infused versions of existing third-party beverages.
The company has announced plans to introduce a CBD
infused beer in partnership with an existing beer
producer and in similar fashion, PURA has partnered
with an existing coffee producer and tea producer to
introduce CBD infused coffee and tea. The company
recently published a presentation on its beer,
coffee and tea initiative that is included in its
entirety on the company's
website.
PURA is already a leading CBD infused beverage
company having produced over $1
million in CBD Beverages in the
United States last year (2018)
and reporting over $1
million in CBD Beverages for
just the first six months of 2019. PURA has targeted $4
million in sales for 2019.
For more information on Puration, visit http://www.purationinc.com
Disclaimer/Safe Harbor:
This news release contains forward-looking
statements within the meaning of the Securities
Litigation Reform Act. The statements reflect the
Company's current views with respect to future
events that involve risks and uncertainties. Among
others, these risks include the expectation that any
of the companies mentioned herein will achieve
significant sales, the failure to meet schedule or
performance requirements of the companies'
contracts, the companies' liquidity position, the
companies' ability to obtain new contracts, the
emergence of competitors with greater financial
resources and the impact of competitive pricing. In
the light of these uncertainties, the
forward-looking events referred to in this release
might not occur. These statements have not been
evaluated by the Food and Drug Administration. These
products are not intended to diagnose, treat, cure,
or prevent any disease.